FR2411174A1 - Nouveaux tetrapeptides, leurs methodes de preparation et d'utilisation - Google Patents

Nouveaux tetrapeptides, leurs methodes de preparation et d'utilisation

Info

Publication number
FR2411174A1
FR2411174A1 FR7834508A FR7834508A FR2411174A1 FR 2411174 A1 FR2411174 A1 FR 2411174A1 FR 7834508 A FR7834508 A FR 7834508A FR 7834508 A FR7834508 A FR 7834508A FR 2411174 A1 FR2411174 A1 FR 2411174A1
Authority
FR
France
Prior art keywords
gly
seryle
alanyle
valyle
threonyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7834508A
Other languages
English (en)
French (fr)
Other versions
FR2411174B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/960,550 external-priority patent/US4232008A/en
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of FR2411174A1 publication Critical patent/FR2411174A1/fr
Application granted granted Critical
Publication of FR2411174B1 publication Critical patent/FR2411174B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1008—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C07K7/062—Serum thymic factor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR7834508A 1977-12-08 1978-12-07 Nouveaux tetrapeptides, leurs methodes de preparation et d'utilisation Granted FR2411174A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85849677A 1977-12-08 1977-12-08
US94053178A 1978-09-08 1978-09-08
US05/960,550 US4232008A (en) 1978-11-17 1978-11-17 Tetrapeptides and methods

Publications (2)

Publication Number Publication Date
FR2411174A1 true FR2411174A1 (fr) 1979-07-06
FR2411174B1 FR2411174B1 (enExample) 1984-05-25

Family

ID=27420392

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7834508A Granted FR2411174A1 (fr) 1977-12-08 1978-12-07 Nouveaux tetrapeptides, leurs methodes de preparation et d'utilisation

Country Status (19)

Country Link
JP (1) JPS5498719A (enExample)
CA (1) CA1120031A (enExample)
CH (1) CH642058A5 (enExample)
DE (1) DE2853002A1 (enExample)
DK (1) DK149595C (enExample)
ES (1) ES475857A1 (enExample)
FI (1) FI67368C (enExample)
FR (1) FR2411174A1 (enExample)
GB (1) GB2014581B (enExample)
GR (1) GR65013B (enExample)
IE (1) IE47611B1 (enExample)
IL (1) IL56150A (enExample)
IT (1) IT1110889B (enExample)
NL (1) NL7812004A (enExample)
NO (1) NO149631C (enExample)
NZ (1) NZ189101A (enExample)
PT (1) PT68883A (enExample)
SE (1) SE444687B (enExample)
YU (1) YU41322B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126009A1 (fr) * 1983-05-16 1984-11-21 Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) Nouveaux dérivés de peptides, leur préparation et leur application comme inhibiteurs de l'élastase
FR2741076A1 (fr) * 1995-11-15 1997-05-16 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4215112A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Tripeptides and methods
US4215111A (en) * 1979-03-14 1980-07-29 Ortho Pharmaceutical Corporation Peptides having ubiquitin-like activity
CA1156220A (en) * 1979-04-26 1983-11-01 George Heavner Method and composition for preparation of h-sar-lys-sar-gln-nh.sub.2
US4426324A (en) * 1979-09-28 1984-01-17 Hoffmann-La Roche Inc. Immunopotentiating peptides
JPS5711950A (en) 1980-06-25 1982-01-21 Kureha Chem Ind Co Ltd Peptide and its synthesis
RU2210382C1 (ru) * 2002-07-09 2003-08-20 Терентьев Александр Александрович Пептид, обладающий иммунорегуляторным свойством, и его композиция

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2544348A1 (de) * 1975-10-03 1977-04-07 Max Planck Gesellschaft L-leucin-13-motilin, verfahren zu dessen herstellung und dasselbe enthaltendes mittel
NL7805717A (nl) * 1977-05-25 1978-11-28 Anvar Polypeptiden met geneeskundige activiteit.
FR2391994A1 (fr) * 1977-05-25 1978-12-22 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese
FR2423481A2 (fr) * 1978-04-21 1979-11-16 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2544348A1 (de) * 1975-10-03 1977-04-07 Max Planck Gesellschaft L-leucin-13-motilin, verfahren zu dessen herstellung und dasselbe enthaltendes mittel
NL7805717A (nl) * 1977-05-25 1978-11-28 Anvar Polypeptiden met geneeskundige activiteit.
FR2391994A1 (fr) * 1977-05-25 1978-12-22 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese
FR2423481A2 (fr) * 1978-04-21 1979-11-16 Anvar Nouveaux polypeptides a activite thymique ou a activite antagoniste et leurs procedes de synthese

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126009A1 (fr) * 1983-05-16 1984-11-21 Etablissement Public dit: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) Nouveaux dérivés de peptides, leur préparation et leur application comme inhibiteurs de l'élastase
FR2546164A1 (fr) * 1983-05-16 1984-11-23 Centre Nat Rech Scient Nouveaux derives de peptides, leur preparation et leur application comme inhibiteurs de l'elastase
FR2741076A1 (fr) * 1995-11-15 1997-05-16 Rech De Pathologie Appliquee S Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
WO1997018239A1 (fr) * 1995-11-15 1997-05-22 Institut Europeen De Biologie Cellulaire Conjugues peptidiques derives des hormones thymiques, leur utilisation a titre de medicament et compositions les contenant
US6211155B1 (en) 1995-11-15 2001-04-03 Institut European De Biologie Cellulaire Peptide conjugates derived from thymic hormones, their use as a medicament and compositions containing them

Also Published As

Publication number Publication date
DK149595C (da) 1987-03-23
FI67368C (fi) 1985-03-11
IE782423L (en) 1979-06-08
GB2014581A (en) 1979-08-30
SE7812614L (sv) 1979-06-09
YU41322B (en) 1987-02-28
IT7852239A0 (it) 1978-12-07
IL56150A (en) 1982-02-28
FR2411174B1 (enExample) 1984-05-25
DK149595B (da) 1986-08-04
YU288078A (en) 1983-02-28
NO784128L (no) 1979-06-11
IT1110889B (it) 1986-01-06
PT68883A (en) 1979-01-01
FI67368B (fi) 1984-11-30
GB2014581B (en) 1982-05-19
JPS6327360B2 (enExample) 1988-06-02
NL7812004A (nl) 1979-06-12
IL56150A0 (en) 1979-03-12
ES475857A1 (es) 1980-01-16
CA1120031A (en) 1982-03-16
DK554078A (da) 1979-06-09
JPS5498719A (en) 1979-08-03
FI783769A7 (fi) 1979-06-09
CH642058A5 (de) 1984-03-30
SE444687B (sv) 1986-04-28
NZ189101A (en) 1984-07-06
NO149631B (no) 1984-02-13
GR65013B (en) 1980-06-12
NO149631C (no) 1984-05-23
IE47611B1 (en) 1984-05-02
DE2853002A1 (de) 1979-06-13

Similar Documents

Publication Publication Date Title
Robey et al. Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity.
Cole et al. Phenotypic and functional analysis of T cells extracted from chronically inflamed human periodontal tissues
FR2411174A1 (fr) Nouveaux tetrapeptides, leurs methodes de preparation et d'utilisation
NO176798C (no) Syntetisk peptid for påvisning av AIDS, fremgangsmåte for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, testsett for in vitro påvisning av antistoffer mot HIV og diagnose av AIDS, ARC og pre-AIDS tilstander
PT879056E (pt) Modulacao da expressao das citocinas th1/th2 atraves de ribavirina em linfocitos t activados
Gonzal et al. Linomide inhibits programmed cell death of peripheral T cells in vivo
Torbohm et al. Modulation of collagen synthesis in human glomerular epithelial cells by interleukin 1
NO893882L (no) Middel til forbedring av lipidmetabolisme og fremgangsmaate ved anvendelse derav.
Lester et al. A postsynthetic modification of human α-fetoprotein controls its immunosuppressive potency
ES8703488A1 (es) Procedimiento para preparar peptidos
Bos et al. Psoriasis infiltrating cell immunophenotype: changes induced by PUVA or corticosteroid treatment in T-cell subsets, Langerhans cells and interdigitating cells
Hemmer et al. The Balearic toad (Bufo viridis balearicus (Boettger, 1881)), human bronze age culture, and Mediterranean biogeography
Burston et al. Intestinal handling of two tetrapeptides by rodent small intestine in vitro
Wallach et al. Enhanced release of lymphotoxins by interferon-treated cells
Katchburian et al. Lysosomes and removal of the basal lamina of ameloblasts in early stages of odontogenesis
Salley et al. The effect of chronic vitamin A deficiency on dental caries in the Syrian hamster
Malavé et al. Modulatory effect of zinc on the proliferative response of murine spleen cells to polyclonal T cell mitogens
Zatz et al. Lymphocyte Populations of AKR/J Mice: II. Effect of Leukemogenesis on Migration Patterns, Response to PHA, and Expression of Theta Antigen
KR900701298A (ko) T-세포 억제작용을 보유한 펩티드
Ryan Inhibition of the immune response by phenylalanine: application to skin transplantation
Doǧan et al. Cyclosporin A enhances T cell‐mediated induction of E‐selectin
Strannegård Lymphocyte stimulation with phorbol myristate acetate in atopic and non-atopic individuals
BR9810884A (pt) Uso de uma preparação de lipìdeo derivada de uma fonte natural enriquecida
Chaouat et al. Immunoactive Products of Placenta. V: Soluble Factors From Murine Placenta Can Block Effector Stages of Maternal Antipaternal Cell‐Mediated Immunity
Alema et al. Site of biosynthesis of brain‐specific proteins in the giant fibre system of the squid

Legal Events

Date Code Title Description
ST Notification of lapse